Other Royalties definition

Other Royalties means all running royalties which Mediwound or its Affiliate actually receive from a Sub-Licensee on a Sub-Licensee’s sales of Product.
Other Royalties shall have the meaning set forth in Section 7.1.4.
Other Royalties means the interests conveyed by the Company to an Other Trustee pursuant to the Other Conveyances.

Examples of Other Royalties in a sentence

  • Mediwound shall be entitled to retain all damages and other sums, so attained by it except for an amount equal to a 20% (twenty percent) royalty thereon as if the same were Other Royalties, after deduction of 50% (fifty percent) of Mediwound’s reasonable legal fees, experts fees and other expenses incurred in prosecuting such claim.

  • Concurrent with the delivery of the Sales report, Licensee will remit payment to Company for any Patent Royalties and Other Royalties due for such calendar quarter as described below.

  • Except with the affirmative vote at a meeting duly called and held in accordance with the provisions of Article V hereof of the Record Date Unit Holders representing a majority of the Units outstanding on the Voting Record Date, the Trustee shall not agree to a dissolution of any Other Trust or (except when necessary to provide for the payment of specific liabilities of any Other Trust or the Trust) to the sale of all or any portion of the Other Royalties.

  • In no event, however, may the Trustee, except with the affirmative vote at a meeting duly called and held in accordance with the provisions of Article V hereof of the Record Date Unit Holders representing a majority of the Units outstanding on the Voting Record Date, agree to any such modification or settlement which would (1) alter the nature of any Other Royalties or (2) change the beneficiary of or the procedures for amending any Other Trust Agreement.

  • If such redesign is impossible or unreasonable such that DexCom is required to pay royalties to such third party ("Other Royalties") in order to offer such Licensed Product in commerce, the royalties payable by DexCom pursuant to Section 4.2 and 4.3 of this Agreement may be reduced by up to [*****] to offset payments by DexCom of Other Royalties, but in no event will the royalties payable by DexCom to SMTLLC be reduced by more than [*****] of the royalties otherwise due to SMTLLC for such Licensed Product.

  • The Trustee may not sell or direct any Other Trustee to sell or otherwise dispose of all or any part of the Royalties, the Other Royalties or any Other Trust Interest for any consideration other than cash.

  • This Agreement and all other agreements to be executed and delivered by the Purchaser hereunder at the Peñasquito Royalty Closing and the Other Royalties Closing constitute and will constitute valid, binding and enforceable obligations of the Purchaser.

  • To the best of Vendor’s knowledge, other than the Pre-emptive Rights, there is no agreement, Contract, option, commitment or other right in favor of, or held by, any Person other than the Purchaser to acquire the Alto Dorado Royalty or any portion thereof and, to the best of its knowledge, there is no agreement, contract, option, commitment or other right in favor of, or held by, any Person other than the Purchaser to acquire any of the Other Royalties or any parts hereof.

  • All covenants and agreements made by the Vendor or KEC in this Agreement or under this Agreement shall survive Peñasquito Royalty Closing and the Other Royalties Closing and any investigation at any time made by or on behalf of the Purchaser, and shall continue in full force and effect for the benefit of the Purchaser.

  • Net Sales (Other Royalties and Sublicense Consideration): LICENSOR to receive [***]% of consideration paid to COMPANY by NOVARTIS under Section 3.02(b) of the NOVARTIS SUBLICENSE AGREEMENT in accordance with Section 4.3(b) of this AGREEMENT as part of the recovery to be received in settlement of the Contract Claim and the Patent Claim.


More Definitions of Other Royalties

Other Royalties means the Royalties not inclusive of the Alto Dorado Royalty;
Other Royalties shall have the meaning set forth in Section 7.3. 1.37 The term "OTHER PARTY AGREEMENTS" shall have the meaning set forth in Section 3.3. 1.38 The term "PATENT COSTS" shall mean the fees and expenses paid to outside legal counsel and experts, and filing, prosecution and maintenance expenses, incurred after the EFFECTIVE DATE in connection with the establishment and maintenance of rights under patents covering any LICENSED PRODUCT, including costs of patent interference, reexamination, reissue, opposition and revocation proceedings. 1.39 The term "PATENT RIGHT(S)" shall mean individually and collectively , GNE PATENTS, LKS PATENTS and JOINT PATENTS. 1.40 The term "PHASE III CLINICAL TRIAL" shall mean a pivotal clinical trial designed to demonstrate statistically whether the LICENSED PRODUCT is safe and effective for use in treating IBD in a manner sufficient to obtain REGULATORY APPROVAL. 1.41 The term "POST-APPROVAL DEVELOPMENT COSTS" shall mean all costs incurred after first REGULATORY APPROVAL of a LICENSED PRODUCT in the OPTION TERRITORY for any development activities related to such LICENSED PRODUCT or any subsequent LICENSED PRODUCT to be developed by the parties. POST-APPROVAL DEVELOPMENT COSTS in the OPTION TERRITORY for any post approval clinical trial shall include all expenses for compensation, benefits and travel and other employee-related expenses, as well as data management, statistical designs and studies, document preparation, and other expenses associated therewith. If additional indications or any new REGULATORY APPROVAL are sought for a LICENSED PRODUCT by the parties in the OPTION TERRITORY, POST-APPROVAL DEVELOPMENT COSTS shall include but are not limited to (i) all costs for research and development, including manufacturing, required to initiate and support clinical trials, (ii) costs of clinical studies for a LICENSED PRODUCT conducted internally or by individual investigators, or consultants directed toward obtaining and/or maintaining REGULATORY APPROVAL of a LICENSED PRODUCT for such additional indication in the OPTION TERRITORY, (iii) costs for preparing, submitting, reviewing or developing data or information for the purpose of submission to the FDA to obtain and/or maintain REGULATORY APPROVAL of a LICENSED PRODUCT for such additional indication or new indication in the OPTION TERRITORY, (iv) costs incurred after REGULATORY APPROVAL of a LICENSED PRODUCT in the OPTION TERRITORY in support of post-launch clinical studies for the L...
Other Royalties but in no event shall any royalties payable to LKS under this Agreement be reduced by more than *.
Other Royalties means the right, title and interest, if any, that was granted to the Vendor and/or KEC in, to, relating to or arising from the 2% net smelter royalties and the 1% net smelter royalties, as the case may be, with respect to the Other Concessions provided in (a) Section 4 of the Termination of Property Rights Agreement or (b) the contractos attached hereto as Schedule B.

Related to Other Royalties

  • Royalties means all royalties, fees, expense reimbursement and other amounts payable by a Loan Party under a License.

  • Royalty Payments has the meaning set forth in Section 7.3.1.

  • Sublicense Fees shall have the meaning set forth in Section 7.6 below.

  • Third Party Royalties means royalties payable by either Party to a Third Party in connection with the manufacture, use or sale of Franchise Products.

  • Sublicense Income means any payments that Company receives from a Sublicensee in consideration of the sublicense of the rights granted Company under Section 2.1., including without limitation license fees, royalties, milestone payments, and license maintenance fees, but excluding the following payments: (a) payments made in consideration for the issuance of equity or debt securities of Company at fair market value, and (b) payments specifically committed to the development of Licensed Products.